Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma

Tsui Lien Mao, Chih Yi Hsu, May J. Yen, Blake Gilks, Jim Jinn Chyuan Sheu, Edward Gabrielson, Russell Vang, Leslie Cope, Robert J. Kurman, Tian Li Wang, Ie Ming Shih

Research output: Contribution to journalArticlepeer-review

33 Scopus citations


Rsf-1 protein is a member of a chromatin-remodeling complex that plays an important role in regulating gene expression and cell proliferation. Our previous study showed that Rsf-1 was an amplified gene that participated in the development of ovarian serous carcinoma. To further elucidate the role of Rsf-1 in ovarian cancer, we studied Rsf-1 immunoreactivity in 294 ovarian tumors of various histologic types. Because the Rsf-1 amplicon overlaps an amplified region reported in breast cancer, we included 782 neoplastic and normal breast tissues for comparison. Immunohistochemistry was performed on tissue microarrays using a 4-tiered scoring system. Overexpression of Rsf-1 was defined as a nuclear immunointensity of 3+ to 4+ because of a strong correlation between 3+ and 4+ immunointensity and Rsf-1 gene amplification, based on our previous fluorescence in situ hybridization analysis. Rsf-1 overexpression was observed in 25% of high-grade ovarian serous carcinomas and in only rare cases (<7%) of low-grade ovarian serous, ovarian endometrioid, and invasive breast carcinomas but not in any ovarian serous borderline tumors, ovarian clear cell carcinomas, ovarian mucinous carcinomas, intraductal carcinomas of the breast, and normal ovaries and breast tissues. Thus, overexpression of Rsf-1 was significantly associated with high-grade ovarian serous carcinoma (P < .05), as compared with other types of ovarian tumors and breast carcinomas. Our results provide evidence that Rsf-1 expression is primarily confined to high-grade serous carcinoma, the most aggressive ovarian cancer. Because Rsf-1 overexpression occurs in only a small number of breast carcinomas, it is unlikely that Rsf-1 is a critical gene in the development of breast carcinoma.

Original languageEnglish (US)
Pages (from-to)1169-1175
Number of pages7
JournalHuman pathology
Issue number9
StatePublished - Sep 2006


  • Breast carcinoma
  • Ovarian serous carcinoma
  • Rsf-1

ASJC Scopus subject areas

  • Pathology and Forensic Medicine


Dive into the research topics of 'Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma'. Together they form a unique fingerprint.

Cite this